Drug-Therapy Problems and Predictors among Hospitalized Heart-Failure Patients: A Prospective Observational Study
- PMID: 33376412
- PMCID: PMC7764776
- DOI: 10.2147/DHPS.S268923
Drug-Therapy Problems and Predictors among Hospitalized Heart-Failure Patients: A Prospective Observational Study
Abstract
Background: Heart-failure patients are at high risk of experiencing drug-therapy problems, owing to polypharmacy, comorbidities, and usually advanced age. Drug-therapy problems can lead to poor clinical outcomes, increased health-care costs and decreased quality of life, and thus strategies for identifying, resolving, and preventing them are urgently needed. Therefore, this study aimed at investigating the incidence and predictors of drug-therapy problems among hospitalized heart-failure patients.
Methods: This hospital-based prospective observational study was conducted from February 1 to May 31, 2014 at Jimma University Specialized Hospital. Patients of either sex aged 18 years and above with chronic heart failure and complete medical records were enrolled. Patients with high-output heart failure, <1 day of hospital stay, unwilling to give written informed consent, and unconscious without caregivers were excluded. Data were collected from medication charts, laboratory reports, patients/caregivers, morning multidisciplinary meetings, and ward rounds. Multivariate binary logistic regression analysis was done to identify independent predictors of drug-therapy problems.
Results: A total of 104 heart-failure patients (mean age 51.20±15.66 years, females 51.9%) were consecutively enrolled, and 95 (91.3%) had experienced at least one drug-therapy problem (total 268, mean 2.82±1.39 encounters per patient). Of these problems, 45.5% were the need for additional drugs, followed by noncompliance (22.0%), inappropriate dosing (9.3%), unnecessary drugs (9.0%), ineffective drugs (8.2%), and adverse drug reactions (6.0%). None of the independent variables was found to be an independent predictor of having at least one drug-therapy problem. However, the number of clinical/pharmacological risk factors (AOR 7.93), female sex (AOR 3.24), and length of hospital stay (AOR 12.98) were predictors of noncompliance.
Conclusion: Patients suffered from a large number of drug-therapy problems. Drugs with survival benefit were underused. Noncompliance and the need for additional drug therapy were the most frequently identified drug-therapy problems. Numbers of clinical/pharmacological risk factors, length of hospital stay, and female sex were identified as predictors for noncompliance.
Keywords: drug-therapy problems; heart failure; predictors.
© 2020 Fentie Wendie and Tarekegn Angamo.
Conflict of interest statement
The authors report no financial or nonfinancial conflicts of interest.
Figures
Similar articles
-
Drug-related problems and its predictors among hospitalized heart failure patients at Jimma Medical Center, South West Ethiopia: prospective interventional study.BMC Cardiovasc Disord. 2022 Sep 19;22(1):418. doi: 10.1186/s12872-022-02859-4. BMC Cardiovasc Disord. 2022. PMID: 36123632 Free PMC article.
-
Drug therapy problems and contributing factors in the management of heart failure patients in Jimma University Specialized Hospital, Southwest Ethiopia.PLoS One. 2018 Oct 23;13(10):e0206120. doi: 10.1371/journal.pone.0206120. eCollection 2018. PLoS One. 2018. PMID: 30352096 Free PMC article.
-
Drug-Related Problems and Associated Factors among Patients Admitted with Chronic Kidney Disease at Jimma University Medical Center, Jimma Zone, Jimma, Southwest Ethiopia: A Hospital-Based Prospective Observational Study.Int J Nephrol. 2019 Oct 20;2019:1504371. doi: 10.1155/2019/1504371. eCollection 2019. Int J Nephrol. 2019. PMID: 31772774 Free PMC article.
-
Drug therapy problems among patients with cardiovascular disease admitted to the medical ward and had a follow-up at the ambulatory clinic of Hiwot Fana Specialized University Hospital: The case of a tertiary hospital in eastern Ethiopia.SAGE Open Med. 2019 Jul 18;7:2050312119860401. doi: 10.1177/2050312119860401. eCollection 2019. SAGE Open Med. 2019. PMID: 31367379 Free PMC article.
-
Prevalence, characteristics and predicting risk factors of adverse drug reactions among hospitalized older adults: A systematic review and meta-analysis.SAGE Open Med. 2021 Aug 18;9:20503121211039099. doi: 10.1177/20503121211039099. eCollection 2021. SAGE Open Med. 2021. PMID: 34422271 Free PMC article. Review.
Cited by
-
Stem Cell-Derived Extracellular Vesicles in the Treatment of Cardiovascular Diseases.Pharmaceutics. 2024 Mar 11;16(3):381. doi: 10.3390/pharmaceutics16030381. Pharmaceutics. 2024. PMID: 38543275 Free PMC article. Review.
-
Drug-related problems and its predictors among hospitalized heart failure patients at Jimma Medical Center, South West Ethiopia: prospective interventional study.BMC Cardiovasc Disord. 2022 Sep 19;22(1):418. doi: 10.1186/s12872-022-02859-4. BMC Cardiovasc Disord. 2022. PMID: 36123632 Free PMC article.
-
Drug therapy problems among hospitalized patients with cardiovascular disease.BMC Cardiovasc Disord. 2024 Jan 15;24(1):50. doi: 10.1186/s12872-024-03710-8. BMC Cardiovasc Disord. 2024. PMID: 38221638 Free PMC article.
-
Medication Related-Problems and Associated Factors Among Patients with Hypertension at a Tertiary Care Hospital in Ethiopia: A Prospective Interventional Study.Integr Blood Press Control. 2023 Nov 30;16:123-136. doi: 10.2147/IBPC.S434072. eCollection 2023. Integr Blood Press Control. 2023. PMID: 38054013 Free PMC article.
-
Definition of Polypharmacy in Heart Failure: A Scoping Review of the Literature.Cardiol Res. 2024 Apr;15(2):75-85. doi: 10.14740/cr1636. Epub 2024 Apr 15. Cardiol Res. 2024. PMID: 38645827 Free PMC article.
References
-
- Gauci M. Evidence-based drug therapy in the management of heart failure. J Malta College Pharm Pract. 2011;17:5–10.
-
- McMurray JJV, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2012;33:1787–1847. - PubMed
LinkOut - more resources
Full Text Sources